While American lawmakers have taken steps to shield US pharma companies from any legal blowback caused by COVID vaccines, drugmakers in Europe haven’t been so lucky. And after widespread skepticism of the AstraZeneca-Oxford vaccine, what was supposed to be the workhorse of the global immunization rollout before reports of rare and deadly blood clots inspired regulators around the comment to either halt the jab, or impose limits on its use.
And now, all these issues will be dredged up again as AstraZeneca is hit by lawsuits filed by the families of those who died from rare blood clots potentially linkted to the vaccine. In what appears to be a first, Sky News reported Monday that the family of an Italian woman who died from a case of vaccine-linked clots are suing to officially establish whether the jab was at fault in her death.
The case involves 55-year-old Augusta Turiaco from Messina, Sicily, who received her COVID jab on March 11, but started experiencing severe symptoms a few days later.
Despite feeling unwell afterwards, Turiaco returned to work, posting two days later to reassure worried friends saying: “Andra tutto bene” – or “everything will be alright” in Italian.
She fell into a coma on March 28 March and died on March 30 March, 19 days after having the AstraZeneca injection. Her conditions also found in others who died after having the Oxford-AstraZeneca vaccine. – READ MORE
Listen to the insightful Thomas Paine Podcast Below --